This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Glaxosmithkline Biologicals Sa, Smithkline Beecham Biologicals S.a.. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 545 
1 out of 75 Years Active: 2007-2010
Title: Innovations by Isabelle Knott
Introduction
Isabelle Knott is a notable inventor based in Rixensart, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of vaccines. With a total of 3 patents to her name, her work focuses on innovative solutions for public health.
Latest Patents
Isabelle Knott's latest patents include groundbreaking inventions related to rotavirus vaccines. One of her patents, titled "Homogeneous attenuated human rotavirus population," provides an attenuated rotavirus population comprising a single variant defined by a nucleotide sequence encoding major viral proteins designated as VP4 and VP7. This invention particularly highlights a rotavirus population designated as P43. Additionally, she has developed a novel formulation for a rotavirus vaccine in the form of a quick-dissolving tablet for immediate dissolution when placed on the tongue. Another patent, "Immunogenic composition of a homogeneous live attenuated human rotavirus population," shares similar features and innovations, emphasizing the importance of her contributions to vaccine development.
Career Highlights
Throughout her career, Isabelle has worked with prominent companies in the biotechnology sector. She has been associated with GlaxoSmithKline Biologicals SA and SmithKline Beecham Biologicals SA, where she has contributed to various research and development projects. Her expertise in vaccine formulation and development has positioned her as a key player in her field.
Collaborations
Isabelle has collaborated with several professionals in her field, including Brigitte Desiree Alberte Colau and Francoise Denamur. These collaborations have further enhanced her research and innovation capabilities.
Conclusion
Isabelle Knott's work in the field of biotechnology, particularly in vaccine development, showcases her innovative spirit and dedication to improving public health. Her patents reflect her commitment to creating effective solutions for combating viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile